Toripalimab in Combination With Axitinib in Patients With Localized Mucosal Melanoma

NCT04180995 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Mucosal Melanoma

Interventions

DRUG: TORIPALIMAB INJECTION(JS001 ) Axitinib tablet (Inlyta®)

Sponsor

Peking University Cancer Hospital & Institute